Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy-Reference-Cited by-同舟云学术

Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy

Published:2010-06 Issue:3 Volume:36 Page:292-299
ISSN:1677-5538
Container-title:International braz j urol
language:
Short-container-title:Int. braz j urol.

Author:

Oliveira Irai S.¹,Pontes-Junior Jose¹,Abe Daniel K.¹,Crippa Alexandre¹,Dall’Oglio Marcos F.¹,Nesralah Adriano J.¹,Leite Katia R. M.¹,Reis Sabrina T.¹,Srougi Miguel¹

Affiliation:

1. University of Sao Paulo Medical School, Brazil

Publisher

FapUNIFESP (SciELO)

Subject

Urology

Link

http://www.scielo.br/pdf/ibju/v36n3/v36n3a05.pdf

Reference25 articles.

1. Proceedings: Etiology, epidemiology, and pathology of prostatic cancer;Franks LM;Cancer,1973

2. Latent prostatic cancer in a consecutive autopsy series;Hølund B;Scand J Urol Nephrol.,1980

3. Canadian Cancer Statistics 2000,2000

4. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer;Epstein JI;JAMA,1994

5. Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression;Choo R;J Urol.,2002

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Senhance Robotic Radical Prostatectomy; a Review of Literature;Acta Clinica Croatica;2022

2. Comparison of Grading Accuracy of Prostate Cancer in Samples Acquired by a Targeted and Systemic Prostate Biopsy;Acta Clinica Croatica;2022

3. Indoleamine 2,3-dioxygenase expression in the prognosis of the localized prostate cancer;International Urology and Nephrology;2020-03-09

4. Diagnostic Performance of Multiparametric Magnetic Resonance Imaging and Fusion Targeted Biopsy to Detect Significant Prostate Cancer;Anticancer Research;2017-12-03

5. Diagnostic performance of 68Gallium-PSMA-11 PET/CT to detect significant prostate cancer and comparison with 18FEC PET/CT;Oncotarget;2017-11-14